RxDoctor Payments Data

Angela Martinsen, PA

Medical · Mobile, ALNPI 1144749821

Payments from drug & device makers

$1,246in general payments, 2019–2025

Across 65 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$566
  • Gilead$260
  • Johnson & Johnson$75
  • AstraZeneca$40
  • Amgen$39
  • Bristol Myers Squibb$35
  • plus $230 from 12 others

What the payments were for

  • Food & beverage$1,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,246 in reported general payments places this provider in the 60th percentile of 175 medical providers in Alabama.

See all medical providers in Alabama

Medicare billing

Part B allowed, 2024
$27,121
Medicare patients
228
Services billed
351

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin29$97,335
CreonLipase/Protease/Amylase23$65,101
LinzessLinaclotide69$54,419
MotegrityPrucalopride Succinate33$19,042
SutabSod Sulf/Pot Chloride/Mag Sulf80$13,009
Pantoprazole Sodium134$2,418
Ursodiol20$2,295
Omeprazole81$2,107
Ondansetron OdtOndansetron41$1,947
Colestipol Hcl13$1,053
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates14$865
Sucralfate13$630
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine15$544
Dicyclomine Hcl19$510
Lactulose23$474

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$566$119,52092 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$15$97,33529 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$28$19,04233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 175 medical providers in Alabama.

Other medical in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →